Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda
In recent years, several studies have suggested that the use of performance and image enhancing drugs via injection is increasing in Australia, with anabolic steroids appearing to be the most commonly used of these drugs. Traditionally the domain of elite athletes and recreational bodybuilders, ster...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Taylor and Francis Ltd
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/30379 |
| _version_ | 1848753072349642752 |
|---|---|
| author | Seear, Kate Fraser, Suzanne Moore, David Murphy, Dean |
| author_facet | Seear, Kate Fraser, Suzanne Moore, David Murphy, Dean |
| author_sort | Seear, Kate |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | In recent years, several studies have suggested that the use of performance and image enhancing drugs via injection is increasing in Australia, with anabolic steroids appearing to be the most commonly used of these drugs. Traditionally the domain of elite athletes and recreational bodybuilders, steroid use may be extending to other groups, including adolescents, gym attendees, professionals and students. Like other forms of injecting drug use, steroid injecting can allow transmission of blood-borne viruses, especially hepatitis C, but little is known about how steroid injecting takes place and how such transmission might occur. Crucially, Australias existing harm reduction framework appears ill-equipped to deal with this emerging trend, and is underprepared to meet the challenges that it may pose. In this commentary, we outline key areas where more research into steroid use in Australia is needed. Improved understandings of the practices and experiences of individuals, who inject steroids, and the possibilities for targeted harm reduction responses, are needed if Australia is to respond to the increase in steroid use effectively. |
| first_indexed | 2025-11-14T08:18:42Z |
| format | Journal Article |
| id | curtin-20.500.11937-30379 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T08:18:42Z |
| publishDate | 2015 |
| publisher | Taylor and Francis Ltd |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-303792017-09-13T15:30:24Z Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda Seear, Kate Fraser, Suzanne Moore, David Murphy, Dean In recent years, several studies have suggested that the use of performance and image enhancing drugs via injection is increasing in Australia, with anabolic steroids appearing to be the most commonly used of these drugs. Traditionally the domain of elite athletes and recreational bodybuilders, steroid use may be extending to other groups, including adolescents, gym attendees, professionals and students. Like other forms of injecting drug use, steroid injecting can allow transmission of blood-borne viruses, especially hepatitis C, but little is known about how steroid injecting takes place and how such transmission might occur. Crucially, Australias existing harm reduction framework appears ill-equipped to deal with this emerging trend, and is underprepared to meet the challenges that it may pose. In this commentary, we outline key areas where more research into steroid use in Australia is needed. Improved understandings of the practices and experiences of individuals, who inject steroids, and the possibilities for targeted harm reduction responses, are needed if Australia is to respond to the increase in steroid use effectively. 2015 Journal Article http://hdl.handle.net/20.500.11937/30379 10.3109/09687637.2015.1061975 Taylor and Francis Ltd restricted |
| spellingShingle | Seear, Kate Fraser, Suzanne Moore, David Murphy, Dean Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda |
| title | Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda |
| title_full | Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda |
| title_fullStr | Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda |
| title_full_unstemmed | Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda |
| title_short | Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda |
| title_sort | understanding and responding to anabolic steroid injecting and hepatitis c risk in australia: a research agenda |
| url | http://hdl.handle.net/20.500.11937/30379 |